Vincerx Pharma Inc.
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 26 institutions reported holding Vincerx Pharma Inc. in their 13F filings, down 2 from Q2 2024. 4 opened new positions and 6 sold out. The largest holders were Armistice Capital, LLC ($1.9M), Prosight Management, LP ($1.6M) and Sage Rhino Capital LLC ($1.2M). 2 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Vincerx Pharma Inc.
- CUSIP
- 92731L106
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $48K |
| Exits | 6 | $178K |
All 13F filers, Q2 2024 → Q3 2024: 893,135 shares bought and 570,601 shares sold, net +322,534 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 26 holders
| Armistice Capital, LLC | 0.05% | Add +36.0% | 2,704,000 | $1.9M |
| Prosight Management, LP | 0.40% | Reduce -11.3% | 2,206,505 | $1.6M |
| Sage Rhino Capital LLC | 0.27% | No change | 1,703,413 | $1.2M |
| Rock Springs Capital Management LP | 0.02% | No change | 891,719 | $638K |
| Point72 Asset Management | 0.00% | No change | 674,193 | $483K |
| Goldman Sachs Group Inc. | 0.00% | Add +0.0% | 631,424 | $452K |
| Vanguard Group Inc. | 0.00% | No change | 627,442 | $449K |
| ExodusPoint Capital Management, LP | 0.00% | Add +13.4% | 542,021 | $388K |
| Marshall Wace, LLP | 0.00% | Add +7.6% | 353,562 | $255K |
| Geode Capital Management, LLC | 0.00% | Add +8.7% | 250,800 | $180K |
| Rubric Capital Management LP | 0.00% | No change | 116,873 | $84K |
| Renaissance Technologies | 0.00% | Reduce -49.3% | 66,001 | $47K |
| State Street Corp. | 0.00% | No change | 57,016 | $41K |
| BlackRock, Inc. | 0.00% | — | 47,080 | $34K |
| Northern Trust Corp. | 0.00% | No change | 34,297 | $25K |
| Susquehanna International Group, LLP | 0.00% | New | 31,980 | $23K |
| Jane Street Group, LLC | 0.00% | New | 20,905 | $15K |
| XTX Topco Ltd | 0.00% | Add +0.8% | 18,320 | $13K |
| Two Sigma Investments, LP | 0.00% | Reduce -16.4% | 14,227 | $10K |
| HRT Financial LP | 0.00% | New | 14,701 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -11.5% | 6,989 | $5K |
| Morgan Stanley | 0.00% | No change | 1,750 | $1K |
| Bank & Trust Co | 0.00% | No change | 1,000 | $716 |
| UBS Group AG | 0.00% | Add +23700.0% | 238 | $171 |
| Bank of America Corp. | 0.00% | Add +0.5% | 211 | $151 |
| JPMorgan Chase & Co. | 0.00% | New | 58 | $42 |
"% of holder's portfolio" is VINCERX PHARMA INC's weight in each manager's 13F, not the share of Vincerx Pharma Inc. the manager owns.